I Markers Del Carcinoma Della Prostata

Armitage T.G. , Cooper E.H. , Newling D.W.W. , Robinson M.R.G. , Appleyard I. : The value of the measurement of serum PSA in patients with benign prostatic hyperplasia and untreated prostate cancer. Brit. J. Urol., 62; 584–589 (1988).

Bahnson R.R. , Catalona W.J. : Adverse implication of acide phosphatase levels in the upper range of normal. J. Urol., 137; 427–430 (1987).

Bruce A.W. , Mahan D.E. , Sullivan L.D. : The significance of prostatic acid phosphatase in adenocarcinoma of the prostate. J. Urol., 125; 357–360 (1981).

Buamah P.K. , Johnson N.P. , Skillen A.W. : Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease. Brit. J. Urol., 62; 581–583 (1988).

Catalona J.W. , Stein A.J. : Staging errors in clinically localized prostatic cancer. J. Urol., 127; 452–456 (1982).

Collier D.S. , Pain J.A. : Acute and chronic retention of urine: relevance of raised serum prostatic phosphatase levels. A prospective study. Urology, 27; 34–37 (1986).

Cooper E.H. , Pidcock N.B. , Daponte D. , Glashan R.W. , Rowe E. , Robinson M.R.G. : Monitoring of prostatic cancer by an enzyme-linked immunosorbent assay of serum prostatic acid phosphatase. Eur. Urol., 9; 17 (1983).

Cooper E.H. , Siddal G.K. : Comparison of gamma-seminoprotein and PSA in the management of prostate cancer. In: Tumor markers in prostate cancer. Symposium Proceeding. Excerpta Medica, 37–46, N.Y. City 1986.

Cooper J.F. , Foti A. : A radioimmunoassay for prostatic acid phosphatase. Methology and range of normal male serum values. Invest. Urol., 12; 98 (1974).

Dejter S. , Martin S. , McPherson R. , Lynch J. :. Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation. Urology, 32; 288–292 (1988).

Fair W.R. , Heston W.D.W. , Kadmon D. , Crane D.B. , Catalona W.J. , Ladenson J.H. , McDonald J.M. , Noll B.W. , Harvey G. : Prostatic cancer, acid phosphatase, creatinine kinase-BB and race: a prospective study. J. Urol., 128; 735 (1982).

Ferro M.A. , Barnes I. , Roberts J.B.M. : Tumor markers in prostatic carcinoma. A comparison of PSA with acid phosphatase. Brit. J. Urol., 60; 69–73 (1987).

Flocks R.H. , Urick V. , Patel C.A. : Studies on the antigenic properties of prostate antigen. J. Urol., 84; 134–143 (1960).

Foti A.G. , Herschman H. , Cooper J.F. : Comparison of human prostatic acid phosphatase by measurement of enzymatic activity and by radioimmunoassay. Clin. Chem., 23; 95 (1977).

Foti A. , Herschman H. , Cooper J.F. : A solid-phase radioimmunoassay for human prostatic acid phosphatase. Cancer Res., 35; 2246 (1975).

Foti A. , Cooper J.F. , Herschman H. : Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase. N. Engl. J. Med., 297; 1357 (1977).

Gitte R. : Acid phosphatase reappraised. N. Engl. J. Med., 297; 1398–1399 (1977).

Giuliani L. , Gilberti C. , Damonte P. , Martorana G. : Utilità del dosaggio dei marcatori biologici circolanti nelle diagnosi, staging e follow-up: background e prospettive. In: I biomarcatori del carcinoma prostatico. Boccardo, Bombardieri, Fabris (eds.), 24–43 (1986).

Gutman A.B. , Gutman E.D. : An acid phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. J. Clin. Invest., 17; 473–476 (1938).

Guzzo C. , Pachas E. , Pinals R. , Kram M.J. : Urinary hydroxyproline excretion in patients with prostatic cancer. Cancer, 24; 382 (1969).

Heller J.E. : Prostatic acid phosphatase its current clinical status. J. Urol., 137; 1091–1103 (1987).

Holmgren J. , Lindholm L. , Persson B. : Detection by monoclonal antibody of carbohydrate antigen CA₅₀ in serum of patients with carcinoma. Brit. Med. J., 288; 1479–1482 (1984).

Howard P.J. jr. , Fraley E. : Elevation of the acid phosphatase in benign prostatic disease. J. Urol., 94; 687 (1965).

Killian C.S. , Emrich L.J. , Vargas P.F. : Relative riability of five serially measured markers for prognosis of progression in prostate cancer. J. Nat. Cancer Inst., 76; 179–185 (1986).

Killian C.S. , Yang N. , Emrich L.S. , Vargas F.P. , Kuriyama M. , Wang M.C. : Prognostic importance of PSA for monitoring patients with stage B₂ to D₁ prostate cancer. Cancer Res., 45; 886–991 (1985).

Killian C.S. , Yang N. , Emtkh L.J. : Prognostic importance of P.S.A. and other markers for monitoring of prostate cancer patients. In: Tumor markers in prostate cancer. Excerpta Medica, 24–36, N.Y. City 1986.

Kuriyama M. , Wang M.C. , Papsidero L.D. , Killian C.S. : Quantitation of prostate specific antigen by sensitive enzyme immunoassay. Cancer Res., 40; 4658–4662 (1980).

Kuriyama M. , Wang M.C. , Lee C.L. , Killian C.S. : Multiple marker evalutation in human prostate cancer with the use of tissue-specific antigens. J. Nat. Cancer Inst., 68; 99–105 (1982).

Kuriyama M. , Wang M.C. , Lee C.L. , Papsidero L.D. , Killian C.S. : Use of human prostate specific antigen in monitoring prostate cancer. Cancer Res., 41; 3874–3876 (1981).

Kuriyama M. , Takeuchi T. : Clinical evaluation of gamma-seminoprotein in prostate cancer. Prostate, in press (1986).

Kuriyama M. : Prostate specific antigen. In: Progress in prostatic cancer, Pagano F. , Zattoni F. (eds.), 21–32 (1986).

Lammel A. , Krieg M. , Becker H. , Braun B. : Discriminative value of serum phosphatases in patients with prostatic carcinoma. Urology, 32; 293–300 (1988).

Lange P.H. , Ercole C.J. , Vessella R.L. : Tumor markers in the follow-up of initial therapy of prostate cancer. Symposium Proceedings. Excerpta Medica, 16–23, N.Y. City 1986.

Lee C.L. , Wang M.C. , Murphy G.P. , Chu T.M. : A solid-phase fluorescent immunoassay for human prostatic acid phosphatase. Cancer Res., 38; 2871 (1978).

Lee C.L. , Li C.Y. , Jou Y.H. , Murphy G.P. , Chu T.M. : Immunochemical characterization of prostatic acid phosphatase with monoclonal antibodies. Ann. N.Y. Acad. Sci., 390; 52 (1982).

Lee C.L. , Chu T.M. , Wajsman L.Z. , Slack N.H. , Murphy G.P. : Value of new fluorescent immunoassay for human prostatic acid phosphatase in prostatic cancer. Urology, 15; 338 (1980).

Liedtke R.J. , Batjer J.D. : Measurement of PSA by radioimmunoassay. Clin. Chem., 30; 649–652 (1984).

Mannini D. , Aiello E. , Maver P. , Corrado G. : La determinazione del PSA sierico nel carcinoma della prostata: Acta Urol. Ital., 2; 69–72 (1988).

Marberger H. , Segal S.L. , Flocks R.H. : Changes in serum acid phosphatase levels consequent to prostatic manipulation or surgery. J. Urol., 78; 287 (1957).

Madji M. , Tabei S.Z. , Castro A. , Chu T.M. , Murphy G.P. , Wang M.C. , Morales A.R. : Prostate specific antigen: an immunohistologic marker for prostatic neoplasma. Cancer, 48; 1229–1232 (1981).

Nissenkorn I. , Mickey D.D. , Miller D.B. , Soloway M.S. : Circadian and day-to-day variation of prostatic acid phosphatase. J. Urol., 127; 1122–1124 (1982).

O'Brien W.M. , Lynch J.H. : Hydroxyproline as a marker for following patients with metastatic prostate cancer. J. Urol., 139; 66–68 (1988).

Pavone Macaluso M. : Cancro della prostata. Acta Urol. Ital., 2; 73–75 (1988).

Pfluger H. , Kircheimer J.C. , Hienert G. , Binder B.R. : Urochinase: A specific marker of metastasation in prostatic carcinoma. 82^nd AUA Meeting. Abstract 44, Anaheim 1987.

Piazza R. , Oliva G. , Vianello F. , Maruzzi D. , Zanotti F. : Valore predittivo dei markers prostatici nei pazienti sottopo-sti a prostatectomia radicale. Acta Urol. Ital., 2; 158 (1988).

Pontes J.E. , Choe B.K. , Rose N.R. , Ercole C. , Pierce J.M. jr. : Clinical evaluation of immunological methods for detection of serum prostatic acid phosphatase. J. Urol., 126; 363 (1981).

Pontes J.E. , Choe B.K. , Rose N.R. and Pierce J.M. jr. : Indirect immunofluorescence for identification of prostatic epithelial cells. J. Urol., 117; 459 (1977).

Pontes J.E. , Choe B.K. , Rose N.R. : Clinical evaluation of immunological methods for detection of serum prostatic acid phosphatase. J. Urol., 126; 363–365 (1981).

Pontes J.E. : Biological markers in prostate cancer. J. Urol., 130; 1037–1047 (1983).

Pontes J.E. : Tumor markers in prostate cancer: a urologist's point of view in tumor markers in prostate cancer. Symposium proceedings. Excerpta Medica, 12–15, N.Y. City 1986.

Romas N.A. , Rose N.R. , Tannebaun M. : Acid phosphatase: new developments. Hum. Pathol, 10; 501–512 (1979).

Romas N.A. : Tumor markers for prostate cancer: update. J. Urol., 137; 85–88 (1987).

Romslo I. : The effect of prostatic surgery of the acid phosphatase level. Scand. J. Urol. Nephrol., 5; 111 (1971).

Salo J.O. , Rannikko S. : The value of acid phosphatase measurements in predicting extraprostatic cancer growth before radical prostatectomy. Brit. J. Urol., 62; 439–442 (1988).

Samuell C.T. , Morgans B.T. , O'Donoghue E.P.N. : Radioimmunoassay for prostatic acid phosphatase in early prostatic carcinoma. Brit. J. Urol., 56; 208–212 (1984).

Siddall J.K. , Cooper E.H. , Newling D.W.W. : An evaluation of the immunochemical measurement of PSA in carcinoma of the prostate. Eur. Urol., 12; 123–130 (1986).

Siddall J.K. , Shetty S.D. , Cooper E.H. : Measurements of serum gamma-seminoprotein and prostate specific antigen evaluated for monitoring carcinoma of the prostate. Clin. Chem., 32; 2040 (1986).

Stamey T.A. , Yang N. , Hay A.R. : PSA as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med., 317; 909–976 (1987).

Vihko P. , Sajanti E. Janne O. , Peltonenn L. , Vihko R. : Serum prostate-specific acid phosphatase: development and validation of a specific radioimmunoassay. Clin. Chem., 24; 1915 (1978).

Vihko P. : Characterization of the principal human prostatic acid phosphatase isoenzyme, purified by affinity chromatography and isoelectric focusing. Part II. Clin. Chem., 24; 1783 (1978).

Vihko P. , Kontturi M. , Lukkarinen O. , Vihko R. : Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and follow-up of patients. J. Urol., 133; 979 (1985).

Zattoni F. , Oliva F. , Vianello F. , Pagano F. : La stadiazione clinica della neoplasia prostatica: limiti e prospettive. Acta Urol. Ital., 2; 157 (1988).

Zanotti F. , Passerini G. , Tasca A. , Scialino G. , Cavazzana A. : Fosfatasi acida e cancro prostatico. Minerva urol., 36; 113–211 ((1985).

Wang M.C. , Valenzuela L.A. , Murphy G.P. : Purification of a human prostate specific antigen. Invest. Urol., 17; 159–163 (1979).

Wajsman Z. , Chu T.M. , Borss D. , Saroff S. , Murphy G.P. , Johnson D.E. , Scott W.W. : Clinical significance of serum alkaline phosphatase in advanced prostatic carcinoma. J. Urol., 119; 224 (1978).

Watson R.A. , Tang D.B. : The predictive value of prostatic acid phosphatase as a screening test. Urology, 16; 242 (1980).

Woodard H.Q. : The clinical significance of serum acid phosphatase. Amer. J. Med., 27; 902 (1959).